Paula O
12-19-2012, 06:54 AM
Passing along a great resource:
Research Highlights: New Agents and Strategies for HER2-Positive Breast Cancer (http://www.google.com/url?q=http%3A%2F%2Flists.clinicaloptions.com%2Ft%2 F32517%2F656889%2F31512%2F0%2F&sa=D&sntz=1&usg=AFQjCNEq__7b5KgNf_LQu8zyW6e9cucsSg)
Download slides from a live symposium conducted at the 2012 San Antonio Breast Cancer Symposium in which Kimberly L. Blackwell, MD; Howard A. Burris III, MD, and Michael F. Press, MD, PhD, provide an overview of current standards and future directions for advanced HER2-positive breast cancer.
http://www.clinicaloptions.com/Oncology/Treatment%20Updates/HER2%20Breast%20Cancer.aspx
Paula
Research Highlights: New Agents and Strategies for HER2-Positive Breast Cancer (http://www.google.com/url?q=http%3A%2F%2Flists.clinicaloptions.com%2Ft%2 F32517%2F656889%2F31512%2F0%2F&sa=D&sntz=1&usg=AFQjCNEq__7b5KgNf_LQu8zyW6e9cucsSg)
Download slides from a live symposium conducted at the 2012 San Antonio Breast Cancer Symposium in which Kimberly L. Blackwell, MD; Howard A. Burris III, MD, and Michael F. Press, MD, PhD, provide an overview of current standards and future directions for advanced HER2-positive breast cancer.
http://www.clinicaloptions.com/Oncology/Treatment%20Updates/HER2%20Breast%20Cancer.aspx
Paula